Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells

References

• Schuchert MJ, Luketich JD, Landreneau RJ. Management of esophageal cancer. Curr Probl Surg 2010;47:845–946.
   Google Scholar
• Lin SH, Chang JY. Esophageal cancer: diagnosis and management. Chin J Cancer 2010;29:843–54.
   Google Scholar
• Dahlberg WK, Azzam EI, Yu Y, Little JB. Response of human tumor cells of varying radiosensitivity and radiocurability to fractionated irradiation. Cancer Res 1999;59:5365–9.
   PubMed Web of Science ®Google Scholar
• Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593–8.
   PubMed Web of Science ®Google Scholar
• Takebayashi Y, Akiyama S, Natsugoe S, Hokita S, Niwa K, Kitazono M, The expression of multidrug resistance protein in human gastrointestinal tract carcinomas. Cancer 1998;82:661–6.
   PubMed Web of Science ®Google Scholar
• Meyers MB, Rittmann-Grauer L, O'Brien JP, Safa AR. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells. Cancer Res 1989;49:3209–14.
   PubMed Web of Science ®Google Scholar
• Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008;38:802–32.
   PubMed Web of Science ®Google Scholar
• Seelig A. A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 1998;251:252–61.
   PubMedGoogle Scholar
• McClean S, Whelan RD, Hosking LK, Hodges GM, Thompson FH, Meyers MB, Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in-vitro exposure to fractionated X-irradiation. Biochim Biophys Acta 1993;1177:117–26.
   Google Scholar
• Uchiumi T, Kohno K, Tanimura H, Matsuo K, Sato S, Uchida Y, Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ 1993;4:147–57.
   PubMedGoogle Scholar
• Chin KV, Tanaka S, Darlington G, Pastan I, Gottesman MM. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 1990;265:221–6.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 2004;91:1543–50.
   PubMed Web of Science ®Google Scholar
• Tong Q, Zhang W, Jin S, Li S, Chen Z. The relationship between p27(kip1) expression and the change of radiosensitivity of esophageal carcinoma cells. Scand J Gastroenterol 2011;46:173–6.
   PubMed Web of Science ®Google Scholar
• Olivieri G, Bodycote J, Wolff S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 1984;223:594–7.
   PubMed Web of Science ®Google Scholar
• Matsuyama A, Inoue H, Shibuta K, Tanaka Y, Barnard GF, Sugimachi K, Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer. Cancer Res 2001;61:5714–17.
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JJ, Al-Sarraf M, Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623–7.
   PubMed Web of Science ®Google Scholar
• Henness S, Davey MW, Harvie RM, Davey RA. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys 2002;54:895–902.
   PubMed Web of Science ®Google Scholar
• Osmak M, Miljanic S, Kapitanovic S. Low doses of gamma-rays can induce the expression of mdr gene. Mutat Res 1994;324:35–41.
   Google Scholar
• Eisenmann S, Voigt W, Muller T, Dempke W. Sequential x-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to Cisplatin in two human teratoma cell lines in vitro. Anticancer Res 2010;30:4471–6.
   Google Scholar
• Seiwert TY, Salama JK, Vokes EE. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 2007;4:156–71.
   PubMedGoogle Scholar
• Neuner G, Patel A, Suntharalingam M. Chemoradiotherapy for esophageal cancer. Gastrointest Cancer Res 2009;3:57–65.
   Google Scholar
• Sakakura C, Miyagawa K, Fukuda KI, Nakashima S, Yoshikawa T, Kin S, Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis. Oncogene 2007;26:5927–38.
   PubMed Web of Science ®Google Scholar
• Suchi K, Fujiwara H, Okamura S, Okamura H, Umehara S, Todo M, Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells. Anticancer Res 2011;31:67–75.
   Google Scholar
• Wen J, Zheng B, Hu Y, Zhang X, Yang H, Li Y, Comparative proteomic analysis of the esophageal squamous carcinoma cell line EC109 and its multi-drug resistant subline EC109/CDDP. Int J Oncol 2010;36:265–74.
   PubMed Web of Science ®Google Scholar
• Chavez JD, Hoopmann MR, Weisbrod CR, Takara K, Bruce JE. Quantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cells. PLoS One 2011;6:e19892.
   PubMed Web of Science ®Google Scholar
• Kuwano M, Oda Y, Izumi H, Yang SJ, Uchiumi T, Iwamoto Y, The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 2004;3:1485–92.
   PubMed Web of Science ®Google Scholar
• Kuwano M, Uchiumi T, Hayakawa H, Ono M, Wada M, Izumi H, The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies. Cancer Sci 2003;94:9–14.
   PubMed Web of Science ®Google Scholar
• Georges E, Sharom FJ, Ling V. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv Pharmacol 1990;21:185–220.
   Google Scholar
• Demeule M, Brossard M, Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 1999;277:F832–40.
   PubMedGoogle Scholar
• Gu Y, Fan S, Liu B, Zheng G, Yu Y, Ouyang Y, TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway. Mol Cell Biochem 2011;357:107–13.
   PubMed Web of Science ®Google Scholar